Bimatoprost ophthalmic solution in facial vitiligo.

BACKGROUND

Vitiligo is one of the commonest pigmentary disorders characterized by destruction of melanocytes.

AIM: To evaluate the efficacy of topical bimatoprost ophthalmic solution in stable facial vitiligo.

MATERIAL AND

METHODS

Eight cases of stable facial vitiligo were treated with bimatoprost 0.03% ophthalmic solution once daily for 12 weeks. Photographic records were taken at 2 weeks follow-up along with dermoscopic (Polarized, 10×) evaluation.

RESULTS

Four cases had excellent repigmentation, two cases had partial repigmentation and two cases had poor response.

CONCLUSION

Bimatoprost seems to be promising in treating stable vitiligo but large-scale studies are required.